Register Login
Register to leave comments
  • News bot April 2, 2026, 12:22 a.m.

    🔍 Krasney Karen (Executive)

    Company: CAPRICOR THERAPEUTICS, INC. (CAPR)

    Report Date: 2026-03-31

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 25,000
    • Total shares sold: 50,000

    Detailed Transactions and Holdings:

    • Acquired 693 shares of Common Stock at $1.39 per share (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 31,240.00 | transaction_form_type: 4
    • Acquired 21,488 shares of Common Stock at $3.74 per share (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 52,728.00 | transaction_form_type: 4
    • Acquired 2,819 shares of Common Stock at $3.18 per share (Direct)
      Date: 2026-03-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 55,547.00 | transaction_form_type: 4
    • Sold 25,000 shares of Common Stock at $30.1174 per share (Direct)
      Date: 2026-03-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 30,547.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 693 shares of Stock Option (Right to Buy) at $1.39 per share (Derivative)
      Date: 2026-03-31 | Code: M | Expires: 2028-01-02 | equity_swap_involved: 0 | shares_owned_after: 2,807.00 | transaction_form_type: 4 | Footnotes: F3, F3, F4
    • Sold 21,488 shares of Stock Option (Right to Buy) at $3.74 per share (Derivative)
      Date: 2026-03-31 | Code: M | Expires: 2031-01-04 | equity_swap_involved: 0 | shares_owned_after: 74,205.00 | transaction_form_type: 4 | Footnotes: F5
    • Sold 2,819 shares of Stock Option (Right to Buy) at $3.18 per share (Derivative)
      Date: 2026-03-31 | Code: M | Expires: 2032-01-03 | equity_swap_involved: 0 | shares_owned_after: 81,261.00 | transaction_form_type: 4 | Footnotes: F6

    Footnotes:

    • F1: Shares were sold pursuant to a 10b5-1 trading plan adopted in December 2025 by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: The price reported on Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.31, inclusive.
    • F3: This option was granted on January 2, 2018 and was previously reported as covering 35,000 shares at an exercise price of $1.57 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.
    • F4: Shares vested 1/48th on the first day of each month commencing February 1, 2018.
    • F5: Shares vested 1/48th on the first day of each month commencing February 1, 2021.
    • F6: Shares vested 1/48th on the first day of each month commencing February 1, 2022.

Search

News categories